Centene Corporation · NYSE:CNC
Centene — Investor Day (June 2022)
51 slides from Centene's investor day presentation, June 2022
Slide 1: Investor Update
CENTENE orporation JUNE 2022 Investor Update
Slide 2: Forward-Looking Statements
Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this presentation are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "in
Slide 3: Agenda
Agenda 8:30 AM ET Introduction Jennifer Gilligan, SVP, Finance & Investor Relations 8:35 AM ET Welcome, Strategic Update Sarah London, Chief Executive Officer 8:50 AM ET Company Performance Brent Layton, President and Chief Operating Officer 9:00 AM ET Healthcare and Legislative Landscape Jon Dinesm
Slide 4: Q&A
Q&A Questions can be submitted through the “Ask a question” box on your screen 4
Slide 5: Welcome, Strategic Update: Sarah London
Welcome, Strategic Update Sarah London Chief Executive Officer
Slide 6: Themes
Themes Platform for Strength of Current Value Creation Long-Term Performance Momentum Growth 6
Slide 7: 2024 Target Adjusted Earnings Per Share
2024 TARGET ADJUSTED EARNINGS PER SHARE (EPS) $7.50 - $7.75 Represents 48% Adjusted EPS growth from 2021 7
Slide 8: Value Creation: Driving Enterprise-wide Performance
Value Creation: Driving Enterprise-wide Coordinated Pipeline Performance of Initiatives Spanning the Entire Organization 8
Slide 9: Value Creation: Driving Enterprise-wide Performance
» Uncovering cost savings across Value Creation: footprint of real estate assets Driving » Pharmacy Benefits Management (PBM) RFP now active Enterprise-wide » More disciplined management of vendor spend Performance » Streamlining core operating model 9
Slide 10: Comprehensive Portfolio Review Progress
Comprehensive Portfolio Review Progress 10
Slide 11: Value Creation: Driving Enterprise-wide Performance
Value Creation: Mission Alignment Driving » Improving Processes » Streamlining Technology Enterprise-wide » Focusing on Members and Providers Performance 11
Slide 12: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 12
Slide 13: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 13
Slide 14: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 14
Slide 15: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 15
Slide 16: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 16
Slide 17: Long-Range Strategic Planning Insights
Long-Range Strategic Planning Insights The Right Starting Point Local Matters Vertical Partnership, Not Vertical Integration Digital Innovation New Growth: Market Makers 17
Slide 18: Company Performance: Brent Layton
Company Performance Brent Layton President & Chief Operating Officer
Slide 19: Our Three Core Products
Our Three Core Products Medicaid Marketplace Medicare Centene is the We show growth largest The #1 year-over-year in our Medicare Medicaid Managed Marketplace carrier Care Organization Advantage product 19
Slide 20: 2022 To Date
2022 To Date New Foster Care New Contract Reprocurement Reprocurement Contract and Implementation in Indiana in Louisiana Reprocurement in Nevada in Missouri 20
Slide 21: National Leader in Managed Care for Children Served in the Child Welfare System
National Leader in Managed Care for Children Served in the Child Welfare System 230,000 children and young adults in 19 states 5 SOLE SOURCE/SPECIALTY CONTRACTS In Texas, Florida, Washington, Illinois, and Missouri 21
Slide 22: Looking Ahead
Looking Ahead 22
Slide 23: Redeterminations
Redeterminations » Developing strategies for member transition and retention after end of public health emergency » Proactive member and provider communication, outreach and support » Strong position to provide coverage through our Marketplace product, Ambetter 23
Slide 24: Ambetter Membership
Ambetter Membership 5 NEW STATES FOR 2022 OPEN ENROLLMENT Kentucky, Louisiana, Nebraska, New Jersey, and Oklahoma 274 NEW COUNTIES FOR 2022 OPEN ENROLLMENT We ended open enrollment with over 2 million members, and as of Q1 we have Need to break up content 2.1M members 24
Slide 25: 2022 New Ambetter Products Offer
Ambetter Select Tailored Networks 2022 New Ambetter Ambetter Value Products Offer PCP Gate-Keeper Model More Choice Ambetter Virtual Access Online Medical Home 25
Slide 26: Wellcare Membership
Wellcare Membership 3 NEW STATES FOR 2022 OPEN ENROLLMENT Massachusetts, Nebraska, and Oklahoma 327 NEW COUNTIES FOR 2022 OPEN ENROLLMENT Medicare Advantage membership in 36 States 26
Slide 27: DSNP Footprint
DSNP Footprint ~350K D-SNP MEMBERS 1.2M DUALLY ELIGIBLE MEMBERS HI AK As of 6/1/2022 27
Slide 28: Value Based Contracting Models
Value Based Contracting Models Fee-for-service + Fee-for-service + Capitation / pay-for-performance Shared Risk Full Risk Lower Higher Degree of Degree of Risk-Sharing Risk-Sharing Fee-for-service + Capitation + Shared Savings Shared Risk 28
Slide 29: Healthcare and Legislative Landscape
Healthcare and Legislative Landscape Jon Dinesman EVP, External Affairs
Slide 30: Affordable Care Act Timeline
OBAMA ADMINISTRATION: 2009 – 2016 TRUMP ADMINISTRATION: 2017 – 2020 BIDEN ADMINISTRATION 2021 – Affordable Health Centene becomes Uncertainty Medicaid grows Global Renewed Care Act Insurance largest Medicaid over attempts in popularity; pandemic commitment signed into Marketplaces and Marketplace to
Slide 31: Where We Are Today
Where We Are Today Public Health eAPTCs Emergency State Activity 31
Slide 32: Value Creation in Action: Jim Murray
Value Creation in Action Jim Murray EVP, Chief Transformation Officer
Slide 33: Recalling the Introduction to Value Creation
Recalling the Introduction to Value Creation Multiple Levers to Drive Margin & EPS Growth SG&A Expense Gross Margin Annual Savings Annual Improvement Strategic Use of Capital ~$700M ~$500M • Share buyback • Portfolio rationalization & • Centralize certain functions • Bid discipline divestitures • Or
Slide 34: Value Creation Strategic Alignment
Value Creation Strategic Alignment Eliminate complexity and leverage scale to deliver operational excellence Value Engage members where, how, and when they Creation want to be met Office Become more data-driven to improve product and capability development, as well as operations Harnessing all parts
Slide 35: Value Creation Scorecard and Estimated Timing
Value Creation Scorecard and Estimated Timing Estimated Run-Rate Estimated Year Timing Select Areas of Focus Savings ($M) Run-Rate Achieved • Real Estate Rationalization Short-Term • Vendor Spend Rationalization $300+ 2023 • Discretionary Spend Evaluation • Centralization of Transactional Activities
Slide 36: Maximizing STARs Performance
Maximizing PEOPLE • Welcome Calls and Member Activation STARs • Call Center Member Support Performance PROCESSES • Appeals • Complaint Tracking Module (CTM) Root Cause Identification and Correction KEY AREAS OF FOCUS TECHNOLOGY • Appeals Platform Technology Infrastructure • HEDIS Reporting • Provide
Slide 37: Financial Update: Drew Asher
Financial Update Drew Asher Chief Financial Officer
Slide 38: 2022 Guidance Update
2022 Guidance Update 2022 Guidance Increased Medicaid April & May Favorable Redeterminations • Utilization in check • 2022 Premium & Service Revenues +$2B • Medicaid eligibility • Continued Medicaid and redeterminations Medicare membership • 2022 Adjusted Diluted EPS assumed to commence growth +$0.1
Slide 39: 2022 Guidance Update
2022 Guidance Update 2022 Guidance Increased Medicaid April & May Favorable • 2022 Premium & Service Redeterminations • Utilization in check Revenues +$2B • Medicaid eligibility • Continued Medicaid and • 2022 Adjusted Diluted EPS redeterminations Medicare membership +$0.15; new guidance assumed to
Slide 40: Managing Through Redeterminations
Managing Through Redeterminations Data Analytics Rates Partnership Membership Past Experiences Individual Cohorts & with Mix Shifts State-by-State Utilization Patterns and Advocacy Engagement Due to continued growth, $7.0B - $7.5B of estimated run-rate revenue reduction from redeterminations, up fro
Slide 41: 2022 Guidance Update
2022 Guidance Update 2022 Guidance Increased Medicaid April & May Favorable Redeterminations • Utilization in check • 2022 Premium & Service Revenues +$2B • Medicaid eligibility • Continued Medicaid and redeterminations Medicare membership • 2022 Adjusted Diluted EPS assumed to commence growth +$0.1
Slide 42: Value Creation: Measuring Progress in 2022
Value Creation: Measuring Progress in 2022 Q1 Q2 Q3 Q4 Award PBM Initiate Pharmacy Platform Contract Standardization Consolidation (#1) RFP issued in Deployment of for 2024 of Call Center Strategically April 2022 Automated Management Price 2023 Bids Provider Issue RFP for Assignment Begin Phase 2 20
Slide 43: Value Creation: Multiple Levers to Drive Margin & EPS Growth
Value Creation: Multiple Levers to Drive Margin & EPS Growth SG&A Expense Gross Margin Annual Savings Annual Improvement Strategic Use of Capital ~$700M ~$500M • Share buyback • Portfolio rationalization & • Centralize certain functions • Bid discipline divestitures • Organizational model • Pharmacy
Slide 44: Value Creation: Real Estate Rationalization
Value Creation: Real Estate Rationalization 65% Reduction One-Time Costs $180M - $200M • Leased space to be downsized. • Estimated one-time pre-tax cost • Annualized pre-tax run rate savings including lease impairments upon completion of leased real • Taking actions to discontinue use of ($750M - $8
Slide 45: Value Creation: Multiple Levers to Drive Margin & EPS Growth
Value Creation: Multiple Levers to Drive Margin & EPS Growth SG&A Expense Gross Margin Annual Savings Annual Improvement Strategic Use of Capital ~$700M ~$500M • Share buyback • Portfolio rationalization & • Centralize certain functions • Bid discipline divestitures • Organizational model • Pharmacy
Slide 46: Strategic Divestitures $2.8B
Strategic Divestitures $2.8B of estimated aggregate sales proceeds Majority of the net proceeds to be used to repurchase stock and the balance to reduce debt Neutral to slightly accretive to Adjusted EPS in first 12 months 46
Slide 47: Value Creation: Multiple Levers to Drive Margin & EPS Growth
Value Creation: Multiple Levers to Drive Margin & EPS Growth Total Adjusted EPS Impact $7.50 to $7.75 ~$2.00 $5.40 $0.10 to $0.35 = 2024 Target Adjusted Diluted EPS(2) Targeted 2024 Original 2022 Other net organic impacts Value Creation Guidance by 2024 (not captured in Aligns with 2024 annual value
Slide 48: Sarah London, Chief Executive Officer
Sarah London Chief Executive Officer
Slide 49: Q&A
Q&A Questions can be submitted through the “Ask a question” box on your screen 49
Slide 50: Appendix
Appendix
Slide 51: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures • Included in this presentation are certain non-GAAP measures. Management believes that non-GAAP financial measures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance mor